Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is an essential resource meticulously crafted for clinical practitioners seeking to deepen their understanding of systemic therapy options and medical management of urologic malignancies, including prostate cancer, bladder cancer, upper tract urothelial carcinoma, and renal cell carcinoma.
Organized by organ system, this authoritative text shines a spotlight on groundbreaking therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune checkpoint inhibitors, immunomodulatory agents, and targeted therapies. Written by leading experts in the field, the book not only reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies, but also delves into critical discussions on indications, outcomes, toxicities, and innovative clinical trial concepts.
Each chapter features a bulleted box of clinical pearls, illuminating the specific roles of Advanced Practice Providers (APPs) in urologic oncology. This makes the book not only informative but also a practical guide for everyday clinical practice.
Designed for a wide audience, including urologists, uro-radiologists, medical clinicians, and family practitioners, this comprehensive guide familiarizes readers with effective systemic therapy regimens for urologic malignancies, along with their expected outcomes and potential side effects. Whether you are looking to enhance your clinical skills or stay updated on the latest advancements in urologic oncology, this book is a vital addition to your medical library.
Unlock the potential of modern urologic cancer therapies and elevate your practice with this indispensable guide!
Authors:
Edouard J. Trabulsi (Editor)
Edition:
1st ed. 2021
Publication Date:
September 29, 2020
